Skip to main content
Steven Pergam, MD, Infectious Disease, Seattle, WA

Steven Pergam MD


Associate Member, Vaccine and Infectious Diseases, Fred Hutchinson Cancer Research Center

Join to View Full Profile
  • 1100 Fairview Ave, N E4-100Seattle, WA 98109

  • Phone+1 206-667-7126

  • Fax+1 206-667-4411

Dr. Pergam is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • U Washington Affil Hosps
    U Washington Affil Hosps2005 - 2008
  • University of New Mexico School of Medicine
    University of New Mexico School of MedicineResidency, Internal Medicine, 1998 - 2001
  • University of Nebraska College of Medicine
    University of Nebraska College of MedicineClass of 1998

Certifications & Licensure

  • MT State Medical License
    MT State Medical License 2022 - 2026
  • WA State Medical License
    WA State Medical License 2017 - 2026
  • NM State Medical License
    NM State Medical License 1998 - 2007
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • How Clean Is the Linen at My Hospital? The Mucorales on Unclean Linen Discovery Study of Large United States Transplant and Cancer Centers  
    Steven A Pergam, Jose Vazquez, Pranatharthi Chandrasekar, Kieren A Marr, Sankar Swaminathan, Michele I Morris, John R Wingard, Lilian Abbo, Sanjay G Revankar, Becky Sm..., Clinical Infectious Diseases
  • A Randomized, Placebo-Controlled Trial of Fidaxomicin for Prophylaxis of Clostridium Difficile Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transpl...  
    Kevin Gregg, Javier A Adachi, Steven A Pergam, Clinical Infectious Diseases

Abstracts/Posters

  • High Incidence of Herpes Zoster after Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis
    Steven A. Pergam, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Impact of Intestinal Microbiota on Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Stem Cell Transplantation 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Authored Content

  • Hemostatic Biomarkers Predict Risk of Thromboembolism (TE), Severe COVID-19 and Mortality: A Report from the National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS)December 2022

Press Mentions

  • With Respiratory Infections Rampant, Experts Urge Masking and Vaccination
    With Respiratory Infections Rampant, Experts Urge Masking and VaccinationMarch 13th, 2025
  • FDA Panel Backs Pfizer's RSV Vaccine for Older Adults
    FDA Panel Backs Pfizer's RSV Vaccine for Older AdultsFebruary 28th, 2023
  • FDA Panel Narrowly Endorses Pfizer Vaccine for RSV in Older Adults
    FDA Panel Narrowly Endorses Pfizer Vaccine for RSV in Older AdultsFebruary 28th, 2023
  • Join now to see all

Grant Support

  • Natural Killer Cell Receptor Diversity And CMV In Hematopoietic Cell TransplantatNational Heart, Lung, And Blood Institute2009–2011

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: